← SynDRA
ISPINESIB
SynDRA canonical compound SYN0007398 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | KIF11 |
| Mechanism of action | Kinesin inhibitor |
All known targets
Mechanisms of action (all sources)
- Kinesin inhibitor
- KIF11 INHIBITOR
- Kinesin-like protein 1 inhibitor
Cross-references
Synonyms
- CK0238273
- ISPINESIB (SB-715992)
- Ispinesib mesylate
- SB-715992
- SB715992
- Ispinesib (SB-715992 /CK0238273)
- SB-715992, CK0238273,Ispinesib
- N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide
- Ispinesib (SB-715992)
- SB 715992
- Ispinesib [INN]
- Ispinesib mesilate
- BKT5F9C2NI
- (R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide
- CHEMBL2347651
- UNII-BKT5F9C2NI
- CK 0238273
- G7X
- N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide
- ISPINESIB [WHO-DD]
- Ispinesib; SB-715992
- Ispinesib - SB-715992
- CHEMBL228814
- SCHEMBL3582165
- CHEBI:94692
- DTXSID20187307
- BCPP000200
- BCP02450
- EX-A2078
- BDBM50382559
- BDBM50431891
- NSC755386
- NSC820548
- s1452
- ZINC11680799
- AKOS025147361
- BCP9000797
- CCG-264892
Look up ISPINESIB in the interactive SynDRA portal →